SENORES PHARMACEUTICALS L Total Liabilities

Latest as of March 2026: Rs6.39 Billion INR ≈ $69.13 Million USD

SENORES PHARMACEUTICALS L total liabilities. Based on the latest financial reports, SENORES PHARMACEUTICALS L (SENORES) has total liabilities worth Rs6.39 Billion INR (≈ $69.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SENORES financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of SENORES PHARMACEUTICALS L (2022–2026)

Total liabilities of SENORES PHARMACEUTICALS L from 2022 to 2026. This chart illustrates how SENORES PHARMACEUTICALS L's total liabilities have evolved over time, based on quarterly financial data.

SENORES PHARMACEUTICALS L Competitors by Total Liabilities

The table below lists competitors of SENORES PHARMACEUTICALS L ranked by their total liabilities.

Company	Country	Total Liabilities
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT JK:LSIP	Indonesia	Rp1.77 Trillion
Jilin Liyuan Precision Manufacturing Co Ltd SHE:002501	China	CN¥835.05 Million
Zhejiang Meili High Technology Co Ltd SHE:300611	China	CN¥3.52 Billion
Rashi Peripherals Limited NSE:RPTECH	India	Rs-20.36 Billion
Hanwha Investment&Securities Co Ltd KO:003530	Korea	₩19.36 Trillion
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	China	CN¥569.41 Million
ZJAMP Group Co Ltd SHE:002758	China	CN¥17.15 Billion
Cuckoo Electronics Co Ltd KO:192400	Korea	₩271.25 Billion

Liability Composition Analysis (2022–2026)

This chart breaks down SENORES PHARMACEUTICALS L's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SENORES PHARMACEUTICALS L total assets.

Liquidity & Leverage Metrics

SENORES PHARMACEUTICALS L Total Liabilities Ratios Explained

SENORES PHARMACEUTICALS L total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.68	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SENORES PHARMACEUTICALS L's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SENORES PHARMACEUTICALS L (2022–2026)

The table below shows the annual total liabilities of SENORES PHARMACEUTICALS L from 2022 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs6.39 Billion ≈ $69.13 Million	+12508.64%
2025-03-31	Rs50.70 Million ≈ $548.31K	-98.70%
2024-03-31	Rs3.90 Billion ≈ $42.20 Million	+356.05%
2023-03-31	Rs855.54 Million ≈ $9.25 Million	+279.20%
2022-03-31	Rs225.62 Million ≈ $2.44 Million	--

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$571.27 Million

Rs52.82 Billion INR

Market Cap Rank

#11194 Global

#563 in India

Share Price

Rs1147.00

Change (1 day)

+2.45%

52-Week Range

Rs710.25 - Rs1550.90

All Time High

Rs1550.90